GLOW capsules
GLOW oral capsules (GHK-Cu + BPC-157 + TB-500 with hyaluronic acid)
Written by Aaron CuhaReviewed Sep 2026
Also known as: Oral GLOW, GLOW oral blend, KLOW capsules
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
This is the GLOW skin blend as a pill instead of a shot. A capsule holds about 2 mg of copper peptide, 500 micrograms of BPC-157, 500 micrograms of TB-500, and 100 mg of hyaluronic acid. Add that up. The three peptides are under 3 mg. The hyaluronic acid is 100 mg. So about 97 percent of what you swallow is a cheap skin ingredient.
What people take it for
- Better skin without needles.
- Hair and nails.
- Joint comfort.
- People who want the blend but will not inject.
What the trials actually showed
Nobody has tested this mix in any form. And nobody has tested any of these three peptides taken by mouth. The copper peptide has only ever been studied as a cream. The best test gave it to 13 people after laser skin work and blinded raters saw no real change. The FDA counted five human studies of BPC-157 and none of them used a shot under the skin, let alone a capsule. TB-500 has no human study by any route. Here is the problem with a peptide pill. Your stomach acid and gut enzymes chew peptides up. That is why real peptide pills need special tricks and huge doses to get anything into the blood. No seller has published a single measurement showing these peptides reach your blood.
What people report
Reports, not trial results
The good
- Skin looking better after a few weeks, which people credit to the copper peptide.
- No needles.
The bad
- Nothing at all, reported more often than with the injected version.
- Mild stomach upset in some people.
- People in the peptide world itself doubt any of it gets absorbed. That is the most common criticism of these capsules.
- You are paying peptide prices for a capsule that is mostly hyaluronic acid.
Where these come from: Peptide forums, skincare forums and seller review pages. People talking, not trial data, and most of them changed their skin routine at the same time.
My bottom line
If this capsule does anything for your skin, the most likely reason is the 100 mg of hyaluronic acid. You can buy that on its own for very little.
An opinion, not a finding. I am a coach, not a doctor.
Overview
The injectable skin blend sold as a swallowed capsule, typically 2 mg GHK-Cu, 500 micrograms each of BPC-157 and TB-500, and 100 mg of hyaluronic acid. The combination has never been tested by any route, and the oral route has never been tested for any of the three peptides. By mass the capsule is about 97% hyaluronic acid.
Oral versions of the copper blends appeared once needles became the obstacle to a wider market. The formula per capsule is usually 2 mg GHK-Cu, 500 micrograms of BPC-157, 500 micrograms of the fragment sold as TB-500, and 100 mg of hyaluronic acid. A KLOW version adds 500 micrograms of KPV.
Start with the mass, because it is startling. Add the peptides up and you get 3 mg. Add the hyaluronic acid and the capsule is about 103 mg. The three peptides are under 3% of the contents and the hyaluronic acid is about 97%. Whatever this product does, most of what you swallow is a common cosmetic humectant sold on its own for a few pounds a month.
Then the route. GHK-Cu's entire human record is topical: a cream on skin, in trials that mostly failed their blinded endpoints, plus one registered gel trial that has not reported. BPC-157's human record was counted by FDA at five studies, none of them subcutaneous, and the oral question is genuinely open rather than settled in either direction, since some of the rodent work was intragastric. The fragment sold as TB-500 has no human study by any route. So an oral capsule is a third administration route for a set of molecules that have been properly studied by essentially none.
Peptides swallowed face stomach acid and gut peptidases, and most do not survive intact in meaningful quantity. That is the ordinary reason oral peptide drugs need absorption enhancers and enormous doses: oral semaglutide is dosed at many times the injected amount and still absorbs a low single-digit fraction. Nobody has measured whether any of these three reaches blood after a capsule, and no vendor publishes such a measurement.
Mechanism of action
Unknown by this route. The mechanisms claimed are the topical and injected mechanisms of the components: copper delivery and collagen signalling for GHK-Cu, repair pathway activity for BPC-157, actin binding for the fragment. Whether any of the three survives the stomach and reaches circulation in a capsule has not been published. Hyaluronic acid taken orally has its own small literature for skin hydration, which is not what this product is sold on.
Human evidence
None for the capsule, none for the combination, and none for any of the three peptides taken by mouth.
- The oral blend: no published study, no registered trial, no absorption data.
- GHK-Cu: human evidence is topical only. Thirteen patients after laser resurfacing showed no significant blinded difference in redness, wrinkles or skin quality. The one registered trial is a gel and has not reported.
- BPC-157: FDA counted five human studies, fewer than 110 subjects total, none by injection under the skin and none longer than two weeks.
- TB-500: no human study by any route; the material is a seven amino acid fragment of thymosin beta 4.
What this does not tell you: No study has measured whether any of these peptides appears in blood after a capsule. Without that, the dose on the label describes what went in the mouth and nothing else.
What it has been measured to do
What people using it report
Uncontrolled and self-selected, so it cannot show that anything works. It is still the best guide on this page to what people actually do with GLOW capsules, what they expect, and what goes wrong. The full account, including the negative reports, is below.
Nothing indexed yet
The 5 citations on this page do not report a result for any of the 36 goals indexed here. Registry entries, pharmacokinetics, safety reporting and regulatory records are not outcome evidence, and most of what sits here is one of those.
Reading the research record
This product is the clearest example in the database of a page that has to be about mass rather than mechanism. Ninety seven percent of the capsule is hyaluronic acid, which has a modest oral skin-hydration literature of its own and costs very little. The three peptides that name the product are the trace ingredients, and none has ever been shown to be absorbed in this form.
The fairest reading is that if this capsule does anything noticeable for skin, the ingredient most likely responsible is the one the marketing does not mention. That is worth knowing before paying peptide prices for it.
The evidence, charted
Fig. 1a · evidence scale
13people, across 1 human study cited here
- 2006 · Archives of Facial Plastic Surgery13100%
The whole total is one study of 13. Counts are the enrollment each human citation on this page states, which includes observational cohorts where nobody was given the compound. 1 further human citation states no participant count and is not counted here. Studies still recruiting are excluded, and only studies cited on this page are counted.
Fig. 1b · evidence mix
2 of 5 citations here are human work, the rest are not.
- Human · given to people240%
- In vitro · cells, tissue or a dish120%
- Review · summarises other work240%
Counted from the citation list on this page, typed as this page types it. It understates any literature larger than the sources we cite, and a review counts once however many studies it covers.
Fig. 2 · evidence over time
Evidence spans 4 distinct years, 2006 to 2026, counted from the citation list on this page.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four jurisdictions shown. A jurisdiction's classification is a regulatory fact, not a verdict on the science; see Legal status below for the full text and any notes.
Fig. 4 · dose response
No human dose response curve exists
We draw this figure where the data supports it. For this compound in humans it does not, so the panel stays empty rather than borrowing an animal curve and implying it transfers.
Fig. 5 · molecular identity
- Modality
- Blend
- Molecular weight
- Not on file
- Half-life
- Stated in words, not a number
- Sequence length
- None on file
see the exact wording below
Half-life as stated on file: Not defined. No absorption or clearance study of these peptides taken by mouth has been published.
No amino acid sequence is on file for GLOW capsules, which is expected: a blend is not built from residues.
Fig. 6 · what is in the vial
66.7%of a 3 mg GLOW capsules vial is GHK-Cu
Label mass from a standard vial, not a dose, and not an assay. The ratio is fixed by the seller, so a draw that hits the amount you want of one component sets the amount of every other component with it. No study has tested this combination in any species.
Key studies & citations
- Human2006
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
Thirteen patients randomised after circumoral CO2 laser resurfacing to a regimen with or without GHK-Cu skin care. Computer analysis and blinded evaluators found no significant difference in resolution of redness, and objective evaluation found no significant improvement in wrinkles or overall skin quality. Only the patients' own questionnaire favoured GHK-Cu, at P = 0.04.
Archives of Facial Plastic Surgery - Human2026
Topical GHK-Cu Gel for Acute Skin Wound Healing
A recruiting phase 2 trial, estimated 60 healthy adults, two punch-biopsy wounds each, every wound randomised to GHK-Cu gel or matching vehicle. Started February 2026 and has not reported. It is the only registered interventional trial of GHK-Cu and it is a gel on skin.
ClinicalTrials.gov - Review2026
FDA briefing document on BPC-157 for the July 2026 PCAC meeting
FDA staff counted five published human studies of BPC-157 totalling fewer than 110 subjects, two of them meeting abstracts only, none dosing longer than two weeks, and none giving the peptide by subcutaneous injection. Staff found no adequate human data and mislabelled products in the market.
FDA - In vitro2012
Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential
A doping control laboratory ran the TB-500 product through high performance liquid chromatography and high resolution mass spectrometry and identified the contents as Ac-LKKTETQ, the acetylated 17 to 23 fragment of thymosin beta 4. Seven amino acids, not the 43 amino acid protein the marketing names.
Drug Testing and Analysis - Review2018
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart and Margolina review the gene and cell data behind GHK-Cu: collagen and elastin synthesis, fibroblast support, anti-inflammatory signalling. All of it topical or in vitro, none of it injected, and none of it establishing a dose for an injection.
International Journal of Molecular Sciences
What users report
Self-reported experiences, not evidence. Nothing below was measured under controlled conditions, and reports like these cannot separate a real effect from placebo, from the training or diet change that accompanied it, or from what the product actually contained. They are here because knowing what people describe, including what goes wrong, is worth reading alongside the studies.
- Skin looking better after a few weeks, which people credit to the copper peptide.
- Nothing at all, reported often, and more often than for the injected blends.
- Preference for the capsule purely because it avoids needles.
- Mild stomach upset in a minority.
- Doubt within the peptide community itself about whether any of the three peptides survives the stomach, which is the most common critical comment on these products.
Sources: Peptide forums including r/peptides, skincare forums and vendor testimonial pages. Uncontrolled self-reports, usually alongside topical routines that changed at the same time.
Frequently asked questions
Do the peptides in this capsule get absorbed?
Nobody has published a measurement. Peptides taken by mouth face stomach acid and gut enzymes, and oral peptide drugs generally need absorption enhancers and much larger doses to reach blood at all. No vendor publishes absorption data for these capsules.
What is most of the capsule?
Hyaluronic acid. At 100 mg against about 3 mg of total peptide, it is roughly 97% of the contents by mass.
Is it safer than injecting?
It avoids injection site reactions and sterility risk, and the copper load per capsule is far smaller than an injectable vial. It also has no demonstrated absorption, so safer and inert are hard to tell apart here.
Has the combination been tested?
No, in any form. There is no study of GHK-Cu with BPC-157 and TB-500 together, injected or swallowed.
Is the KLOW capsule different?
It adds 500 micrograms of KPV to the same base. KPV has no human data by any route, so the addition changes the label rather than the evidence.